Results 31 to 40 of about 3,014,693 (296)
Myostatin/Smad2/Smad3 pathway define a differential clinical phenotype in COPD-associated sarcopenia
ERJ Open ResearchBackground Sarcopenia, defined as the loss of muscle mass and function, represents one of the most relevant comorbidities in patients with COPD even at early stages.
Adriana Núñez-Robainas +4 more
doaj +1 more source
Journal of Cachexia, Sarcopenia and Muscle, 2023 Background Cancer cachexia is a syndrome that does not fully recover with nutritional support and causes appetite loss and body weight loss. It worsens a patient's quality of life and prognosis. In this study, the epidemiology of cachexia in lung cancer,
Takehito Shukuya +13 more
doaj +1 more source
The Microbiota and Cancer Cachexia [PDF]
International Journal of Molecular Sciences, 2019 Cancer cachexia is a multifactorial syndrome defined by weight loss, muscle wasting, and systemic inflammation. It affects the majority of patients with advanced cancer and is associated with poor treatment response, early mortality and decreased quality of life.
Kelly M. Herremans +3 more
openaire +2 more sources
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series [PDF]
The use of patient-reported outcomes (PROMs) of quality of life (QOL) is common in cachexia trials. Patients' self-report on health, functioning, wellbeing, and perceptions of care, represent important measures of efficacy.
Cancer Cachexia Endpoints Working Group
core +3 more sources
The urgent need to improve childhood cancer cachexia [PDF]
, 2022 Clinical care and research around cancer cachexia in children is lacking. Cachexia increases treatment-related toxicity and long-term morbidity and potentially affects mortality.
Bonetto, Andrea +5 more
core +1 more source
Cancer cachexia: Focus on cachexia factors and inter-organ communication
Chinese Medical Journal. Cancer cachexia is a multi-organ syndrome and closely related to changes in signal communication between organs, which is mediated by cancer cachexia factors. Cancer cachexia factors, being the general name of inflammatory factors, circulating proteins,
Yongfei Wang +5 more
doaj +1 more source
Palliative Care, 2017 Background: Cancer cachexia is a catabolic syndrome associated with uncontrolled muscle breakdown. There may be associated fat loss. Occurring in high frequency in advanced cancer, it is an indicator of poor prognosis.
Eric Prommer
doaj +1 more source
Role of Complementary and Alternative Medicine in the Management of Cancer Cachexia
Asia-Pacific Journal of Oncology Nursing, 2021 Cancer cachexia is an important concern in cancer patients in view of advanced stage at presentation. The treatment goal for cachexia is the reversal of the loss of body weight and muscle mass with a variety of pharmacological agents.
Abhishek Shankar +5 more
doaj +1 more source
Clinical Framework for Quality Improvement of Cancer Cachexia
Asia-Pacific Journal of Oncology Nursing, 2018 The objective of this article is to introduce the Clinical Framework for Quality Improvement of Cancer Cachexia (Cachexia Care Framework) as a tool to demonstrate the relevance of integrating the clinical components of cancer cachexia and the ...
Clara Granda-Cameron, Mary Pat Lynch
doaj +1 more source
Randomised controlled trial of fish oil supplement to treat cancer cachexia [PDF]
, 2015 Patients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times.
Baughan, C +10 more
core